{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:24:57Z","timestamp":1784309097460,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Critically ill patients suffer from a wide variety of clinical events, most of them leading to pro-inflammatory states such as sepsis or simply as consequence of major surgery. Many of these patients develop forms of acute kidney injury, heart or acute liver failure during intensive care. Lipid signaling is critically involved in triggering systemic inflammation processes, pain and vascular tone. We therefore hypothesized that fatty-acid-derived lipid mediators might be regulated during inflammatory stages and other clinical events in critically ill patients and might serve as potential biomarker candidates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and study design<\/jats:title><jats:p>Using liquid chromatography-tandem mass spectrometry (LC-MS\/MS), we determined the levels of 53 lipid mediators in plasma from nine patients. These patients were hospitalized at Frankfurt University Hospital\u2019s intensive care unit (ICU) after cardiac surgery. Inflammatory stages were illustrated over time using clinically established biomarkers such as interleukin-6 (IL-6) and leukocyte count. Normal range values of the lipids were obtained from healthy volunteers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Plasma levels clearly outside the normal range were observed for 22 of 53 lipid mediators, of which 13 were increased (including ceramides Cer (d18:0\/18:0), Cer (d18:1\/16:0), Cer (d18:1\/18:1), glucosyl-ceramide GluCer (d18:1\/24:1), lactosylceramide LacCer (d18:1\/18:0), and LacCer (d18:1\/24:1), 6-keto-prostaglandin F1alpha (6-keto-PGF1alpha), 11,12- and 14,15-DHET and 1- and 2-arachidonoyl glycerol (1-AG and 2-AG), Sphingosine SPH (d18:1) and 20-HETE. Furthermore, nine lipids were decreased (Cer (d18:1\/24:0), LacCer (d18:1\/16:0), LacCer (d18:1\/24:0), sphingosine-1-phosphate S1P (d18:1), S1P (d18:0), the lysophosphatidic acids LPA (16:0), LPA (18:0), LPA (18:1) and 9-HODE. Among increased lipids, the remarkable changes in 1-AG, 2-AG, and to a lower extent of 6-keto-PGF<jats:sub>1-alpha<\/jats:sub> plasma levels showed a certain agreement with inflammatory phases. Furthermore, 6-keto-PGF1<jats:sub>alpha<\/jats:sub> had its peak shortly before initiation of continuous veno-venous hemodialysis (at least in 5 of the observed patients), 2-AG was elevated in all our nine patients during (right) heart failure in the context of either re-opening patient\u2019s chest, implementation of veno-arterial ECMO or at least while significantly increasing the amount of catecholamines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In this pilot trial we identified several evaluated lipids in critically ill patients representing either potentially (patho-) physiologically relevant mediators of the pro-inflammatory processes and during heart failure or possible markers preceding veno-venous hemodialysis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1148806","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T04:12:08Z","timestamp":1736223128000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of fatty acid-derived lipids in critically ill patients after cardiac surgery yields novel pathophysiologically relevant mediators with possible relevance for systemic inflammatory reactions"],"prefix":"10.3389","volume":"15","author":[{"given":"Holger","family":"Neb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Urbschat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Heinicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Angioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Steinhilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Piesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Ferreir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gurke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Utech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Meybohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten J\u00fcrgen","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13054\u2013015-1089\u20130","article-title":"Decreased serum concentrations of sphingosine-1-phosphate in sepsis","volume":"19","author":"Winkler","year":"2015","journal-title":"Crit Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000814","article-title":"Sphingosine-1-phosphate: A potential biomarker and therapeutic target for endothelial dysfunction and sepsis","volume":"47","author":"Winkler","year":"2017","journal-title":"Shock"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14236","article-title":"Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption","volume":"144","author":"Vutukuri","year":"2018","journal-title":"J Neurochem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/CCM.0000000000002014","article-title":"Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes","volume":"45","author":"Dalli","year":"2017","journal-title":"Crit Care Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182416f05","article-title":"Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients","volume":"40","author":"Bruegel","year":"2012","journal-title":"Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-016-4226-x","article-title":"Plasma phospholipid fatty acid profile is altered in both septic and non-septic critically ill: A correlation with inflammatory markers and albumin","volume":"52","author":"Novak","year":"2017","journal-title":"Lipids"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/00003246\u2013199911000\u201300015","article-title":"Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome","volume":"27","author":"Delogu","year":"1999","journal-title":"Crit Care Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2014\u2013000056","article-title":"Discrimination of sepsis stage metabolic profiles with an LC\/MS-MS-based metabolomics approach","volume":"1","author":"Su","year":"2014","journal-title":"BMJ Open Respir Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3181820d48","article-title":"Correlation between IL-6 levels and the systemic inflammatory response score: can an IL-6 cutoff predict a SIRS state","volume":"65","author":"Giannoudis","year":"2008","journal-title":"J Trauma"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4067\/S0034-98872001000400002","article-title":"Estudio de la cin\u00e9tica de citoquinas en sepsis grave y su relaci\u00f3n con mortalidad y score de disfunci\u00f3n org\u00e1nica","volume":"129","author":"Dougnac","year":"2001","journal-title":"Rev Med Chil"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01753.x","article-title":"A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients","volume":"127","author":"Fokkema","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.03.021","article-title":"Anandamide deficiency and heightened neuropathic pain in aged mice","volume":"71","author":"Bishay","year":"2013","journal-title":"Neuropharmacology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15252\/emmm.201505677","article-title":"Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP","volume":"8","author":"Vogt","year":"2016","journal-title":"EMBO Mol Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/cc4854","article-title":"The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database","volume":"10","author":"Harrison","year":"2006","journal-title":"Crit Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2019.06.004","article-title":"Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma - LC-MS\/MS method validation and pre-analytical characteristics","volume":"204","author":"Gurke","year":"2019","journal-title":"Talanta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.prostaglandins.2012.06.002","article-title":"Analysis of sphingolipid and prostaglandin synthesis during zymosan-induced inflammation","volume":"99","author":"Linke","year":"2012","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1613246113","article-title":"Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain","volume":"113","author":"Sisignano","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms18071532","article-title":"Vitamin D supplementation enhances C18(dihydro)ceramide levels in type 2 diabetes patients","volume":"18","author":"Koch","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.02.61","article-title":"A modified Sequential Organ Failure Assessment score using the Richmond Agitation-Sedation Scale in critically ill patients","volume":"8","author":"Viglino","year":"2016","journal-title":"J Thorac Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022852","article-title":"Plasma ceramide levels are elevated in patients with early coronary atherosclerosis and endothelial dysfunction","volume":"11","author":"Akhiyat","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma ceramides","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfac002","article-title":"The biological variability of plasma ceramides in healthy subjects","volume":"7","author":"Ramos","year":"2022","journal-title":"J Appl Lab Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12933\u2013023-01845\u20130","article-title":"Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes","volume":"22","author":"Denimal","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MCHD-0035\u20132016","article-title":"Lipid mediators in inflammation","volume":"4","author":"Bennett","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.plefa.2003.08.005","article-title":"Involvement of eicosanoids in the hypothermic response to lipopolysaccharide during endotoxemia in rats","volume":"70","author":"Azab","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-1078fje","article-title":"Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death","volume":"17","author":"Ejima","year":"2003","journal-title":"FASEB J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prostaglandins.2006.12.004","article-title":"Prostacyclin in sepsis: a systematic review","volume":"83","author":"Zardi","year":"2007","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01687","article-title":"Platelets in sepsis: an update on experimental models and clinical data","volume":"10","author":"Assinger","year":"2019","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M200401-JLR200","article-title":"Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients","volume":"44","author":"Drobnik","year":"2003","journal-title":"J Lipid Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41569\u2013021-00536\u20131","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/abio.2001.5015","article-title":"Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock","volume":"294","author":"Wang","year":"2001","journal-title":"Anal Biochem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.prostaglandins.2015.09.005","article-title":"Lipopolysaccharide suppresses carboxylesterase 2g activity and 2-arachidonoylglycerol hydrolysis: A possible mechanism to regulate inflammation","volume":"121","author":"Szafran","year":"2015","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10\u2013176602","article-title":"Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation","volume":"25","author":"Alhouayek","year":"2011","journal-title":"FASEB J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.03.002","article-title":"Functional redundancy between canonical endocannabinoid signaling systems in the modulation of anxiety","volume":"82","author":"Bedse","year":"2017","journal-title":"Biol Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0090\u20136980(02)00060\u20136","article-title":"The cannabinoid receptors","author":"Howlett","year":"2002","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.12.11.1035","article-title":"Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension","volume":"12","author":"Varga","year":"1998","journal-title":"FASEB J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1271\u201304.2004","article-title":"A novel role of lactosylceramide in the regulation of lipopolysaccharide\/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases","volume":"24","author":"Pannu","year":"2004","journal-title":"J Neurosci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.82.5.540","article-title":"Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites","volume":"82","author":"Arai","year":"1998","journal-title":"vitro. Circ Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.RA120000984","article-title":"Different rates of flux through the biosynthetic pathway for long-chain versus very-long-chain sphingolipids","volume":"61","author":"Zelnik","year":"2020","journal-title":"J Lipid Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/1742\u20132094-7\u20132","article-title":"Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia","volume":"7","author":"Schlachetzki","year":"2010","journal-title":"J Neuroinflamm"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1998.274.4.C1129","article-title":"Norepinephrine stimulates arachidonic acid release from vascular smooth muscle via activation of cPLA2","volume":"274","author":"LaBelle","year":"1998","journal-title":"Am J Physiol"},{"key":"B43","first-page":"25","article-title":"Functional analysis of eicosanoids from white blood cells in sepsis and SIRS","author":"Baenkler","year":"2006","journal-title":"J Physiol Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1148806\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:43:16Z","timestamp":1738330996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1148806\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2024.1148806"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1148806","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"1148806"}}